New York State Medicaid Coverage Policy and Billing Guidance for the Administration of COVID-19 Vaccines

Updates as of 10/27/2022 are highlighted in yellow

  • Guidance is also available in Portable Document Format (PDF)

This guidance sets forth New York State (NYS) Medicaid´s reimbursement policy for the administration of COVID-19 vaccines approved by the FDA or authorized for emergency use and instructions for providers to bill the cost of administration of authorized COVID-19 vaccine. Information about vaccines receiving EUA by the FDA can be found on the COVID-19 Vaccines web page.

NY Medicaid´s policy for the administration of COVID-19 vaccine will continue to remain in effect in accordance with the Public Readiness and Emergency Preparedness Act (PREP Act). As additional COVID-19 vaccines become available under an EUA, or are otherwise approved by the FDA, this billing guidance will be updated as needed.


I. NYS Medicaid Coverage Policy

This coverage policy applies to both Medicaid fee-for-service (FFS) and Medicaid Managed Care (MMC).

A. NYS Medicaid Will Not Reimburse for the Cost of COVID-19 Vaccine

  1. Payment will not be made to NYS Medicaid providers for the cost of COVID-19 vaccine because the vaccine is available at no cost to providers. Providers must not bill the Current Procedural Terminology (CPT) code for the vaccine.
  2. In order to obtain COVID-19 vaccine at no cost, Medicaid enrolled providers must be legally authorized to administer the vaccine and also enroll as COVID-19 vaccine providers with the Centers for Disease Control and Prevention (CDC), the NYS Department of Health Bureau of Immunization, or the NYC Department of Health and Mental Hygiene (NYCDOHMH) Bureau of Immunization. Such providers are considered qualified providers by the Medicaid program for the purpose of COVID-19 vaccine administration.
  3. For information on how to enroll in the NYS COVID-19 Vaccination Program and how to register for the NYSIIS or CIR, please visit COVID-19 Vaccine Information for Providers.
  4. Note that this program is distinct from the Vaccines for Children (VFC) Program and separate enrollment is required.

B. Reimbursement for Administration of Authorized COVID-19 Vaccines

  1. The NYS Medicaid program, including the Medicaid FFS program and MMC, will reimburse NYS Medicaid enrolled and qualified providers for the administration of COVID-19 vaccines that have been issued an EUA by the FDA for the prevention of COVID-19.
  2. Reimbursement for administration of COVID-19 vaccines may be based on a patient-specific order or non-patient specific order ("standing order"). These orders must be kept on file by the provider. Standing orders enable assessment and vaccination of the patient without the need for clinician examination or a patient-specific order from the attending provider at the time of the patient interaction. For more information, please see:
  3. The ordering provider´s National Provider Identifier (NPI) is required on the Medicaid claim. Ordering providers, including MMC network providers, are required to be enrolled in the NYS Medicaid program (except pharmacists.)
  4. Providers are prohibited from charging Medicaid members a co-payment or any cost sharing responsibility for the COVID-19 vaccine or the administration of the COVID-19 vaccine.
  5. Providers must not bill NYS Medicaid for the administration of the COVID-19 vaccine to members who are also enrolled in Medicare. Dually eligible enrollees will continue to access full coverage of immunization services through Medicare.

C. Coverage of Preventative Counseling for the COVID-19 Vaccine

Effective December 1, 2021, NYS Medicaid, including MMC Plans, will reimburse qualified NYS Medicaid enrolled providers for COVID-19 vaccination counseling to Medicaid members to encourage the administration of COVID-19 vaccines. NYS Medicaid has updated the coverage and billing guidance for COVID-19 vaccination counseling. The updated COVID-19 vaccine guidance document Updated Coverage Criteria for COVID-19 Vaccine Counseling can be found on the COVID-19 Guidance for Medicaid Providers webpage.


II. NYS Medicaid FFS Billing Instructions and Fees

The following billing instructions and fees apply to Medicaid FFS.

A. Qualified Hospital Outpatient Departments, Federally Qualified Health Centers
               (including School Based Health Centers designated as Federally Qualified Health Centers),
               Office-Based Practitioners, and Ambulance Providers

  1. NYS Medicaid enrolled hospital outpatient departments, free-standing diagnostic and treatment centers (D&TCs), Federally Qualified Heath Centers (FQHCs), School Based Health Centers designated as an FQHC (SBHC/FQHC), private office-based practitioners, and ambulance providers can bill NYS Medicaid for COVID-19 vaccine administration administered to NYS Medicaid FFS members in accordance with Table 1 below.
Table 1
CPT Code Manufacturer & COVID-19 Vaccine Administration CPT Code Short Descriptions Fee Effective for Dates of Service on or after: Fee Effective for Dates of Service on or after:
0001A Pfizer-BioNTech - ADM SARSCOV2
30MCG/0.3ML - 1st Dose
$13.23 12/11/2020-3/31/2021 $40.00 4/1/2021
0002A Pfizer-BioNTech - ADM SARSCOV2
30MCG/0.3ML - 2nd Dose
$13.23 12/11/2020-3/31/2021 $40.00 4/1/2021
0003A Pfizer-BioNTech - ADM SARSCOV2
30MCG/0.3ML - 3rd Dose
N/A 8/12//2021 $40.00 8/12/2021
0004A Pfizer-BioNTech - ADM SARSCOV2
30MCG/0.3ML - Booster Dose
N/A 9/22//2021 $40.00 9/22/2021 through 8/31/22
0011A Moderna - ADM SARSCOV2
100MCG/0.5ML - 1st Dose
$13.23 12/18/2020-3/31/2021 $40.00 4/1/2021
0012A Moderna - ADM SARSCOV2
100MCG/0.5ML - 2nd Dose
$13.23 12/18/2020-3/31/2021 $40.00 4/1/2021
0013A Moderna - ADM SARSCOV2
100MCG/0.5ML - 3rd Dose
N/A 8/12//2021 $40.00 8/12/2021
0031A Janssen - ADM SARSCOV2
VAC AD26 .5ML
$13.23 2/27/2021-3/31/2021 $40.00 4/1/2021
0034A Janssen - ADM SARSCOV2
VAC AD26 .5ML - Booster Dose
N/A 10/20/2021 $40.00 10/20/2021
0041A Novavax - ADM SARSCOV2 VAC
5MCG/0.5ML - 1st Dose
N/A 7/13/2022 $40.00 7/13/2022
0042A Novavax - ADM SARSCOV2 VAC
5MCG/0.5ML - 2nd Dose
N/A 7/13/2022 $40.00 7/13/2022
0044A Novavax - ADM SARSCOV2 VAC
5MCG/0.5ML - Booster Dose
N/A 10/19/2022 $40.00 10/19/2022
0051A Pfizer-BioNTech - ADM SARSCOV2
30MCG TRS-SUCR - 1st Dose
N/A 1/3/2022 $40.00 1/3/2022
0052A Pfizer-BioNTech - ADM SARSCOV2
30MCG TRS-SUCR - 2nd Dose
N/A 1/3/2022 $40.00 1/3/2022
0053A Pfizer-BioNTech - ADM SARSCOV2
30MCG TRS-SUCR - 3rd Dose
N/A 1/3/2022 $40.00 1/3/2022
0054A Pfizer-BioNTech - ADM SARSCOV2
30MCG TRS-SUCR - Booster Dose
N/A 1/3/2022 $40.00 1/3/2022 through 8/31/2022
0064A Moderna - ADM SARSCOV2 50MCG/0.25ML - Booster Dose N/A 10/20/2021 $40.00 10/20/2021 through 8/31/2022
0071A Pfizer-BioNTech - ADM SARSCOV2
10MCG/0.2ML Trs-Sucr (ages 5-11) - 1st Dose
N/A 11/03/2021 $40.00 11/03/2021
0072A Pfizer-BioNTech - ADM SARSCOV2
10MCG/0.2ML Trs-Sucr (ages 5-11) - 2nd Dose
N/A 11/03/2021 $40.00 11/03/2021
0073A Pfizer-BioNTech - ADM SARSCOV2
10MCG/0.2ML Trs-Sucr (ages 5-11) - 3rd Dose
N/A 1/3/2022 $40.00 1/3/2022
0074A Pfizer-BioNTech - ADM SARSCOV2
10MCG/0.2ML Trs-Sucr (ages 5-11) - Booster Dose
N/A 5/17/2022 $40.00 5/17/2022 to 10/12/2022
0081A Pfizer-BioNTech - ADM SARSCOV2
3MCG/0.2ML Trs-Sucr (ages 6mos-4yrs) - 1st Dose
N/A 6/17/2022 $40.00 6/17/2022
0082A Pfizer-BioNTech - ADM SARSCOV2
3MCG/0.2ML Trs-Sucr (ages 6mos-4yrs) - 2nd Dose
N/A 6/17/2022 $40.00 6/17/2022
0083A Pfizer-BioNTech - ADM SARSCOV2
3MCG/0.2ML Trs-Sucr (ages 6mos-4yrs) - 3rd Dose
N/A 6/17/2022 $40.00 6/17/2022
0091A Moderna - ADM SARSCOV2 50MCG/0.5ML (6yrs - 11yrs) - 1st Dose N/A 6/17/2022 $40.00 6/17/2022
0092A Moderna - ADM SARSCOV2 50MCG/0.5ML (6yrs - 11yrs) - 2nd Dose N/A 6/17/2022 $40.00 6/17/2022
0093A Moderna - ADM SARSCOV2 50MCG/0.5ML (6yrs - 11yrs) - 3rd Dose N/A 6/17/2022 $40.00 6/17/2022
0094A Moderna - ADM SARSCOV2 50MCG/0.5ML - Booster Dose N/A 3/29/2022 $40.00 3/29/2022 through 8/31/2022
0111A Moderna - ADM SARSCOV2
25MCG/0.25ML (ages 6mos - 5yrs) - 1st Dose
N/A 6/17/2022 $40.00 6/17/2022
0112A Moderna - ADM SARSCOV2
25MCG/0.25ML (ages 6mos - 5yrs) - 2nd Dose
N/A 6/17/2022 $40.00 6/17/2022
0113A Moderna - ADM SARSCOV2 25MCG/0.25ML (6mos-5yrs) - 3rd Dose N/A 6/17/2022 $40.00 6/17/2022
0124A Pfizer-BioNTech - ADM SARSCOV2
Bivalent - 30MCG/0.3ML - Booster Dose
N/A 8/31/2022 $40.00 8/31/2022
0134A Moderna - ADM SARSCOV2
Bivalent - 50MCG/0.25ML - Booster Dose
N/A 8/31/2022 $40.00 8/31/2022
0144A Moderna - ADM SARSCOV2
Bivalent - 25MCG/0.25ML - Booster Dose (6 - 11yrs)
N/A 10/12/2022 $40.00 10/12/2022
0154A Pfizer-BioNTech - ADM SARSCOV2
Bivalent - 10MCG/0.2ML - Booster Dose (5 - 11yrs)
N/A 10/12/2022 $40.00 10/12/2022

NOTE: Practitioner and Ordered Ambulatory claims submitted prior to June 1, 2021 for dates of service on or after April 1, 2021 that were paid at $13.23 will be automatically reprocessed at the new $40.00 administration fee. Providers do not need to submit claim adjustments.

  1. Hospital outpatient departments, D&TCs, and FQHCs should bill an ordered ambulatory claim for COVID-19 vaccine administration.
    Note: SBHC/FQHCs providing COVID-19 vaccine administration to Medicaid FFS and Managed Care members will be required to append the "HA" modifier to the appropriate vaccine administration CPT code from Table 1 above.
  2. Office-based practitioners should bill a professional claim for COVID-19 vaccine administration.
  3. The COVID-19 vaccine administration CPT codes above include the actual work of administering the vaccine, including all necessary counseling provided to patients and/or caregivers for the dose administered, required vaccination reporting, and updating of electronic records. See section C above regarding COVID-19 vaccine counseling.
  4. NYS Medicaid enrolled providers, if within their scope of practice, can bill an Evaluation and Management (E&M) visit on the same day as the COVID-19 vaccine administration, when additional services are provided that are beyond the components represented in the COVID-19 vaccine administration code, and when all of the key components of the E&M code have been provided and documented.
  5. Hospital outpatient departments, D&TCs, and FQHCs providing comprehensive clinic services in addition to and beyond the scope of the COVID-19 vaccine administration service (see #4 & #6 above) can bill an appropriate APG or PPS claim for the medical services provided and can bill a separate ordered ambulatory claim for the COVID-19 vaccine administration.
  6. When the only service provided is the COVID-19 vaccine administration, only an ordered ambulatory claim for the vaccine administration can be submitted.
  7. Ambulance providers have been assigned Category of Service code (COS) "0282" and should bill a professional claim using the COVID-19 vaccine administration codes in Table 1. Ambulance provider claims for COVID-19 vaccine administration should be identified as a non-emergency service by reporting the "Emergency Indicator" as "N" No prior approval/prior authorization is required.
    NOTE: As of June 25, 2021, with the expiration of the New York State Declared Disaster Emergency, ambulance providers may only bill for Covid-19 vaccinations administered by paramedics.
  8. Medicaid providers administering a COVID-19 vaccine to Medicaid members with Family Planning only coverage should bill a separate claim for COVID-19 vaccine administration using ICD-10 diagnosis code Z23 (encounter for immunization) as the primary diagnosis on the claim with the appropriate COVID-19 vaccine administration CPT code from Table 1 representing the COVID-19 vaccine administered.

B. Qualified Pharmacies

The following billing instructions and fees apply to the Medicaid FFS program.

  1. Pharmacies affiliated with a point-of-dispensing (POD) site, such as a skilled nursing facility, residential facility, or mobile vaccination site must have the pharmacy operating site enrolled with NYS Medicaid FFS.

The pharmacy must submit via NCPDP D.0, in the Claim Segment field 436-E1 (Product/Service ID Qualifier), a value of "09" (HCPCS), which qualifies the code submitted in field 407-D7 (Product/Service ID) as a procedure code. In field 407-D7 (Product/Service ID), enter the Procedure code from Table 2 for the appropriate vaccine administration. For example, submit the claim line with the Procedure code "0001A" (Immunization Administration). Do not submit another claim line for the vaccine procedure code as the vaccine is being provided free of charge. Pharmacies will bill with a quantity of "1" and a day supply of "1".

NOTE: Authorized pharmacy personnel may provide the COVID-19 vaccine to persons ages three and older in accordance with the PREP Act.

NCPDP D.0 Claim Segment Field Value
436-E1 (Product/Service ID Qualifier) Value of "09" (HCPCS), which qualifies the code submitted in field 407-D7 (Product/Service ID) as a procedure code
407-D7 (Product/Service ID) Enter an applicable procedure code listed in Table 2
442-E7 (Quantity Dispensed) Enter the value of "1" for the procedure administration code in Table 2
405-D5 (Day Supply) Enter the value of "1"

Refer to the NCPDP D.0 Companion Guide.

Table 2
CPT Code Manufacturer & COVID-19 Vaccine Administration CPT Code Short Descriptions Fee Effective for Dates of Service on or after: Fee Effective for Dates of Service on or after:
0001A Pfizer-BioNTech - ADM SARSCOV2
30MCG/0.3ML - 1st Dose
$13.23 12/11/2020-3/31/2021 $40.00 4/1/2021
0002A Pfizer-BioNTech - ADM SARSCOV2
30MCG/0.3ML - 2nd Dose
$13.23 12/11/2020-3/31/2021 $40.00 4/1/2021
0003A Pfizer-BioNTech - ADM SARSCOV2
30MCG/0.3ML - 3rd Dose
N/A 8/12//2021 $40.00 8/12/2021
0004A Pfizer-BioNTech - ADM SARSCOV2
30MCG/0.3ML - Booster Dose
N/A 9/22//2021 $40.00 9/22/2021 through 8/31/2022
0011A Moderna - ADM SARSCOV2
100MCG/0.5ML - 1st Dose
$13.23 12/18/2020-3/31/2021 $40.00 4/1/2021
0012A Moderna - ADM SARSCOV2
100MCG/0.5ML - 2nd Dose
$13.23 12/18/2020-3/31/2021 $40.00 4/1/2021
0013A Moderna - ADM SARSCOV2
100MCG/0.5ML - 3rd Dose
N/A 8/12//2021 $40.00 8/12/2021
0031A Janssen - ADM SARSCOV2
VAC AD26 .5ML
$13.23 2/27/2021-3/31/2021 $40.00 4/1/2021
0034A Janssen - ADM SARSCOV2
VAC AD26 .5ML - Booster Dose
N/A 10/20/2021 $40.00 10/20/2021
0041A Novavax - ADM SARSCOV2 VAC
5MCG/0.5ML - 1st Dose
N/A 7/13/2022 $40.00 7/13/2022
0042A Novavax - ADM SARSCOV2 VAC
5MCG/0.5ML - 2nd Dose
N/A 7/13/2022 $40.00 7/13/2022
0044A Novavax - ADM SARSCOV2 VAC
5MCG/0.5ML - Booster Dose
N/A 10/19/2022 $40.00 10/19/2022
0051A Pfizer-BioNTech - ADM SARSCOV2
30MCG TRS-SUCR - 1st Dose
N/A 1/3/2022 $40.00 1/3/2022
0052A Pfizer-BioNTech - ADM SARSCOV2
30MCG TRS-SUCR - 2nd Dose
N/A 1/3/2022 $40.00 1/3/2022
0053A Pfizer-BioNTech - ADM SARSCOV2
30MCG TRS-SUCR - 3rd Dose
N/A 1/3/2022 $40.00 1/3/2022
0054A Pfizer-BioNTech - ADM SARSCOV2
30MCG TRS-SUCR - Booster Dose
N/A 1/3/2022 $40.00 1/3/2022 through 8/31/2022
0064A Moderna - ADM SARSCOV2 50MCG/0.25ML - Booster Dose N/A 10/20/2021 $40.00 10/20/2021 through 8/31/2022
0071A Pfizer-BioNTech - ADM SARSCOV2
10MCG/0.2ML Trs-Sucr (ages 5-11) - 1st Dose
N/A 11/03/2021 $40.00 11/03/2021
0072A Pfizer-BioNTech - ADM SARSCOV2
10MCG/0.2ML Trs-Sucr (ages 5-11) - 2nd Dose
N/A 11/03/2021 $40.00 11/03/2021
0073A Pfizer-BioNTech - ADM SARSCOV2
10MCG/0.2ML Trs-Sucr (ages 5-11) - 3rd Dose
N/A 1/3/2022 $40.00 1/3/2022
0074A Pfizer-BioNTech - ADM SARSCOV2
10MCG/0.2ML Trs-Sucr (ages 5-11) - Booster Dose
N/A 5/16/2022 $40.00 5/17/2022 to 10/12/2022
0081A Pfizer-BioNTech - ADM SARSCOV2
3MCG/0.2ML Trs-Sucr (ages 6mos-4yrs) - 1st Dose
N/A 6/17/2022 $40.00 6/17/2022
0082A Pfizer-BioNTech - ADM SARSCOV2
3MCG/0.2ML Trs-Sucr (ages 6mos-4yrs) - 2nd Dose
N/A 6/17/2022 $40.00 6/17/2022
0083A Pfizer-BioNTech - ADM SARSCOV2
3MCG/0.2ML Trs-Sucr (ages 6mos-4yrs) - 3rd Dose
N/A 6/17/2022 $40.00 6/17/2022
0091A Moderna - ADM SARSCOV2 50MCG/0.5ML (6yrs - 11yrs) - 1st Dose N/A 6/17/2022 $40.00 6/17/2022
0092A Moderna - ADM SARSCOV2 50MCG/0.5ML (6yrs - 11yrs) - 2nd Dose N/A 6/17/2022 $40.00 6/17/2022
0093A Moderna - ADM SARSCOV2 50MCG/0.5ML (6yrs - 11yrs) - 3rd Dose N/A 6/17/2022 $40.00 6/17/2022
0094A Moderna - ADM SARSCOV2 50MCG/0.5ML - Booster Dose N/A 3/29/2022 $40.00 3/29/2022 through 8/31/2022
0111A Moderna - ADM SARSCOV2
25MCG/0.25ML (ages 6mos - 5yrs) - 1st Dose
N/A 6/17/2022 $40.00 6/17/2022
0112A Moderna - ADM SARSCOV2
25MCG/0.25ML (ages 6mos - 5yrs) - 2nd Dose
N/A 6/17/2022 $40.00 6/17/2022
0113A Moderna - ADM SARSCOV2 25MCG/0.25ML (6mos-5yrs) - 3rd Dose N/A 6/17/2022 $40.00 6/17/2022
0124A Pfizer-BioNTech - ADM SARSCOV2
Bivalent - 30MCG/0.3ML - Booster Dose
N/A 8/31/2022 $40.00 8/31/2022
0134A Moderna - ADM SARSCOV2
Bivalent - 50MCG/0.25ML - Booster Dose
N/A 8/31/2022 $40.00 8/31/2022
0144A Moderna - ADM SARSCOV2
Bivalent - 25MCG/0.25ML - Booster Dose (6 - 11yrs)
N/A 10/12/2022 $40.00 10/12/2022
0154A Pfizer-BioNTech - ADM SARSCOV2
Bivalent - 10MCG/0.2ML - Booster Dose (5 - 11yrs)
N/A 10/12/2022 $40.00 10/12/2022

NOTE: Pharmacy claims for dates of service on or after April 1, 2021 that were submitted prior to June 1, 2021 and were paid $13.23 will be automatically reprocessed by eMedNY and will pay the $40.00 administration fee. Providers do not need to submit claim adjustments. * If a claim was denied for the administration of a 3rd dose prior to 8/23/2021, the pharmacy will need to re-submit the claim for reimbursement.

  1. Please see the July 2020 Medicaid Update for further guidance on origin code and serial number values that must be submitted on the claim for "Pharmacy dispensing" when applicable for non-patient specific orders. In the origin code use "5" and the corresponding serial number of "99999999" for "Pharmacy dispensing" when applicable for non-patient specific orders.
NCPDP D.0 Claim Segment Field Value
444-E9 (Pharmacist ID) Enter Pharmacist NPI number
411-DB (Prescriber ID) Please leave blank

Updates to procedure codes will be available.


C. Qualified Other Rate-Based Providers

The following billing instructions and fees apply to Medicaid FFS.

  1. The provider types listed below may bill Medicaid FFS and MMC plans for administration of authorized COVID-19 vaccine when administered by provider or facility staff to Medicaid members in a residential or other institutional setting.
  2. The administration fee is in addition to the rate (i.e. per diem, per visit, per hour) reimbursed to the provider and must be billed to Medicaid separately.
  3. Rate-based providers may also bill for COVID-19 vaccine administration on a stand-alone claim when other services are not provided.
  4. The providers identified below have been enrolled under COS 0268 and will be issued the rate codes identified in Table 3 below for billing purposes:
    • Skilled Nursing Facilities (SNFs)
    • Certified Home Health Agencies (CHHAs)
    • Hospice
    • Adult Day Health Care (ADHC)
    • Inpatient Hospitals
    • Voluntary Foster Care Agencies (VFCAs)
    • Assisted Living Programs (ALPs)
  5. Rate-based providers administering a COVID-19 vaccine to Medicaid members with Family Planning only coverage should bill a separate claim for COVID-19 vaccine administration using the appropriate rate code representing the COVID-19 vaccine administered from Table 3 representing the COVID-19 vaccine administered with ICD-10 diagnosis code Z23 (encounter for immunization) as the primary diagnosis on the claim and the appropriate COVID-19 vaccine administration CPT code representing the COVID-19 vaccine administered from Table 2.
Table 3 - Rate codes representing the administration of the Pfizer-BioNTech and Moderna bivalent vaccine booster doses will be published when available.
Rate Code Rate Code Description Fee Effective for Dates of Service on or after: Fee Effective for Dates of Service on or after:
5497 PFIZER - COVID-19 Vaccine Administration - 1st Dose $13.23 12/11/2020-3/31/2021 $40.00 4/1/2021
5498 PFIZER - COVID-19 Vaccine Administration - 2nd Dose $13.23 12/11/2020-3/31/2021 $40.00 4/1/2021
5508 PFIZER - COVID-19 Vaccine Administration - 3rd Dose N/A 8/12//2021 $40.00 8/12/2021
5514 PFIZER - COVID-19 Vaccine Administration - Booster Dose - 0004A N/A 9/22//2021 $40.00 9/22/2021 through 8/31/2022
5499 MODERNA - COVID-19 Vaccine Administration - 1st Dose $13.23 12/18/2020-3/31/2021 $40.00 4/1/2021
5500 MODERNA - COVID-19 Vaccine Administration - 2nd Dose $13.23 12/18/2020-3/31/2021 $40.00 4/1/2021
5509 MODERNA - ADM SARSCOV2
100MCG/0.5ML - 3rd Dose
N/A 8/12//2021 $40.00 8/12/2021
6118 MODERNA - ADM SARSCOV2
50MCG/0.5ML - Booster Dose
N/A 3/29/2022 $40.00 3/29/2022
5507 JANSSEN - COVID-19 Vaccine Administration $13.23 2/27/2021-3/31/2021 $40.00 4/1/2021
5519 JANSSEN - COVID-19 Vaccine Administration - Booster Dose N/A 10/20/2021 $40.00 10/20/2021
5570 Novavax - ADM SARSCOV2 VAC
5MCG/0.5ML - 1st Dose
N/A 7/13/2022 $40.00 7/13/2022
5571 Novavax - ADM SARSCOV2 VAC
5MCG/0.5ML - 2nd Dose
N/A 7/13/2022 $40.00 7/13/2022
TBD Novavax - ADM SARSCOV2 VAC
5MCG/0.5ML - Booster - 0044A
N/A 10/19/2022 $40.00 10/19/2022
5510 Pfizer - COVID VAC (TRS-SUC) - DOSE 1 - 0051A N/A 1/3/2022 $40.00 1/3/2022
5511 Pfizer - COVID VAC (TRS-SUC) - DOSE 2 - 0052A N/A 1/3/2022 $40.00 1/3/2022
5512 Pfizer - COVID VAC (TRS-SUC) - DOSE 3 - 0053A N/A 1/3/2022 $40.00 1/3/2022
5513 Pfizer - COVID VAC (TRS-SUC) - BOOSTER - 0054A N/A 1/3/2022 $40.00 1/3/2022 through 8/31/2022
5515 MODERNA - ADM SARSCOV2
50MCG/0.25ML - Booster Dose - 0064A
N/A 10/20/2021 $40.00 10/20/2021 through 8/31/2022
5516 Pfizer-BioNTech - ADM SARSCOV2
10MCG/0.2ML Trs-Sucr (ages 5-11) - 1st Dose
N/A 11/03/2021 $40.00 11/03/2021
5517 Pfizer-BioNTech - ADM SARSCOV2
10MCG/0.2ML Trs-Sucr (ages 5-11) - 2nd Dose
N/A 11/03/2021 $40.00 11/03/2021
5540 Pfizer-BioNTech - ADM SARSCOV2
10MCG/0.2ML Trs-Sucr (ages 5-11) - 3rd Dose
N/A 1/3/2022 $40.00 1/3/2022
5542 Pfizer-BioNTech - ADM SARSCOV2
10MCG/0.2ML Trs-Sucr (ages 5-11) Booster Dose - 0074A
N/A 5/16/2022 $40.00 5/17/2022 to 10/12/2022
5556 Pfizer-BioNTech - ADM SARSCOV2
3MCG/0.2ML Trs-Sucr (ages 6mos-4yrs) - 1st Dose - 0081A
N/A 6/17/2022 $40.00 6/17/2022
5557 Pfizer-BioNTech - ADM SARSCOV2
3MCG/0.2ML Trs-Sucr (ages 6mos-4yrs) - 2nd Dose - 0082A
N/A 6/17/2022 $40.00 6/17/2022
5558 Pfizer-BioNTech - ADM SARSCOV2
3MCG/0.2ML Trs-Sucr (ages 6mos-4yrs) - 3rd Dose - 0083A
N/A 6/17/2022 $40.00 6/17/2022
5567 Moderna - ADM SARSCOV2 50MCG/0.5ML (6yrs - 11yrs) - 1st Dose N/A 6/17/2022 $40.00 6/17/2022
5568 Moderna - ADM SARSCOV2 50MCG/0.5ML (6yrs - 11yrs) - 2nd Dose N/A 6/17/2022 $40.00 6/17/2022
5569 Moderna - ADM SARSCOV2 50MCG/0.5ML (6yrs - 11yrs) - 3rd Dose N/A 6/17/2022 $40.00 6/17/2022
6118 Moderna - ADM SARSCOV2 50MCG/0.5ML - Booster Dose - 0094A N/A 3/29/2022 $40.00 3/29/2022 through 8/31/2022
5559* Moderna - ADM SARSCOV2
25MCG/0.25ML (ages 6mos-5yrs) - 1st Dose - 0111A
N/A 6/17/2022 $40.00 6/17/2022
5560* Moderna - ADM SARSCOV2
25MCG/0.25ML (ages 6mos-5yrs) - 2nd Dose - 0112A
N/A 6/17/2022 $40.00 6/17/2022
5566 Moderna - ADM SARSCOV2 25MCG/0.25ML - (6mos - 5yrs) - 3rd Dose - 0113A N/A 6/17/2022 $40.00 6/17/2022
TBD Pfizer-BioNTech - ADM SARSCOV2
Bivalent - 30MCG/0.3ML - Booster Dose - 0124A
N/A 8/31/2022 $40.00 8/31/2022
TBD Moderna - ADM SARSCOV2
Bivalent - 50MCG/0.5ML - Booster Dose - 0134A
N/A 8/31/2022 $40.00 8/31/2022
TBD Moderna - ADM SARSCOV2
Bivalent - 25MCG/0.25ML - Booster Dose (6 - 11 yrs) - 0144A
N/A 8/31/2022 $40.00 10/12/2022
TBD Pfizer-BioNTech - ADM SARSCOV2
Bivalent - 10MCG/0.2ML - Booster Dose (5 - 11 yrs) - 0154A
N/A 8/31/2022 $40.00 10/12/2022
Rate codes representing the administration of the Pfizer-BioNTech and Moderna bivalent vaccine booster doses will be published when available.

NOTE: Rate-based claims for dates of service on or after April 1, 2021 will be automatically adjusted to reflect the new $40.00 administration fee. Providers will not have to take any further action.

*Rate Code activation letters were sent to rate-based providers for rate codes 5559 and 5560 with inaccurate descriptions identifying incorrect age parameters for these COVID-19 vaccine administration rate codes. The correct descriptions for rate codes 5559 and 5560 are listed above in table 3.


III. Medicaid Managed Care

A. MMC Coverage Policy

The Medicaid coverage policy in Section I above applies to all types of MMC Plans.


B. MMC Reimbursement

The COVID-19 vaccine administration fees and billing instructions in Section II above are specific to Medicaid FFS. For individuals enrolled in MMC, providers should check with the individual´s MMC Plan for implementation details, reimbursement fees and billing instructions.

  1. Effective April 1, 2021, MMC Plans will reimburse providers no less than the Medicaid FFS rate for COVID-19 vaccine administration.
  2. MMC Plans must cover the cost of vaccine administration by qualified providers who do not participate in the MMC Plan´s network.
  3. Rate-based and office-based provider reimbursement for the vaccine administration must be made separately from visit reimbursement, as detailed in Section II.

Additional Resources


Questions

  • Medicaid FFS coverage and policy questions should be directed to the Office of Health Insurance Programs, Division of Program Development and Management, at (518) 473-2160 or FFSMedicaidPolicy@health.ny.gov.
  • MMC reimbursement, billing, and/or documentation requirement questions should be directed to the enrollee´s MMC plan.
  • Medicaid FFS claim questions should be directed to the eMedNY Call Center at (800) 343-9000.
  • Medicaid FFS Pharmacy Policy questions should be directed to (518) 486-3209 or NYRx@health.ny.gov.